Lung Cancer Update
by Dr. Neil Love
Non-Small Cell Lung Cancer — A Presentation by Dr Julia Rotow on the…
About this podcast
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.
Episodes
The newest 20 of 66 episodes
- Non-Small Cell Lung Cancer — A Presentation by Dr Julia Rotow on the Potential Role of PD-1 x VEGF Bispecific Antibodies · 24 min · Season 26 Episode 56Featuring a slide presentation from Dr Julia Rotow, including the following topics: • Rationale and potential clinical role of PD-1/PD-L1 x vascular endothelial growth factor…
- Lung Cancer — Proceedings from a Symposium Held in Conjunction with the American Oncology Network · 51 min · Season 26 Episode 55Featuring perspectives from Dr Stephen V Liu and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics: • Introduction (0:00) • EGFR Mutations (2:23)…
- For Oncology Nurses: Non-Small Cell Lung Cancer with a ROS1 Fusion — An Interview with Dr Alexander E Drilon · 58 min · Season 24 Episode 54Featuring an interview with Dr Alexander E Drilon, including the following topics: • Overview of targetable biomarkers in lung cancer (0:00) • Biomarker testing for genomic…
- Non-Small Cell Lung Cancer — Targeting KRAS G12C · 58 min · Season 24 Episode 53Featuring perspectives from Prof Solange Peters and Dr Joshua K Sabari, including the following topics: • Introduction (0:00) • Best Option for Your Patient (1:28) • Biological…
- Lambert-Eaton Myasthenic Syndrome in Small Cell Lung Cancer — An Interview with Prof Ticiana Leal · 55 min · Season 24 Episode 52Featuring an interview with Prof Ticiana Leal, including the following topics: • Pathophysiology and clinical signs and symptoms (0:00) • Screening and/or diagnostic approaches…
- Small Cell Lung Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting · 1 h 59 min · Season 24 Episode 51Featuring perspectives from Dr Anne Chiang, Dr Apar Kishor Ganti, Dr Luis Paz-Ares and Dr Misty Dawn Shields, moderated by Dr Shields, including the following topics: •…
- Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances in Therapeutic Targets Beyond EGFR · 59 min · Season 24 Episode 50Featuring perspectives from Dr John V Heymach and Dr Maurice Pérol, including the following topics: • Introduction: Relative Impact of Targeted Treatment (00:00) • HER2…
- HER2-Altered Non-Small Cell Lung Cancer — 5-Minute Journal Club: Microlearning Activity 3 · 30 min · Season 24 Episode 49Featuring perspectives from Dr Joshua K Sabari, including the following topics: • Jänne PA et al. Final analysis results and patient-reported outcomes from DESTINY-Lung02 — A…
- HER2-Altered Non-Small Cell Lung Cancer — 5-Minute Journal Club: Microlearning Activity 2 · 17 min · Season 24 Episode 48Featuring perspectives from Dr Joshua K Sabari, including the following topics: • Heymach JV et al. Zongertinib in previously treated HER2-mutant non-small cell lung cancer. N…
- EGFR-Mutated Non-Small Cell Lung Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting · 1 h 57 min · Season 24 Episode 47Featuring perspectives from Dr Sarah B Goldberg, Dr Jonathan Goldman, Dr Joel W Neal, Dr Antonio Passaro and Dr Jacob Sands, moderated by Dr Sands, including the following…
- HER2-Altered Non-Small Cell Lung Cancer — Rapid Case Review · 28 min · Season 24 Episode 46Featuring an interview with Dr Mark Jeng and Dr Joshua K Sabari, including the following topics: • Case: A woman in her late 90s with recurrent HER2-mutant metastatic non-small…
- Nonmetastatic Non-Small Cell Lung Cancer — An Interview with Dr Jamie E Chaft · 60 min · Season 24 Episode 45Featuring an interview with Dr Jamie E Chaft, including the following topics: • Case: A man in his early 70s with a 40 to 50 pack-year history of smoking and cT2bN1 squamous…
- For Oncology Nurses: Strategies to Safely and Effectively Implement Antibody-Drug Conjugates — Proceedings from the 2026 Annual ONS Congress · 1 h 28 min · Season 24 Episode 44Featuring perspectives from Ms Courtney Arn, Ms Jamie Carroll, Dr Edward B Garon, Dr Heather McArthur and Dr Kathleen N Moore, moderated by Dr Moore, including the following…
- Targeted Therapies for Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit · 50 min · Season 24 Episode 43Featuring perspectives from Dr Lyudmila Bazhenova and Dr Corey J Langer, including the following topics: • Introduction (0:00) • Therapeutic Approaches Targeting HER2 and RET —…
- EGFR-Mutated Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit · 51 min · Season 24 Episode 42Featuring perspectives from Dr Jonathan Goldman and Dr Zofia Piotrowska, including the following topics: • Introduction (0:00) • Current Management of Metastatic EGFR-Mutated…
- First-Line and Maintenance Therapy for Patients with Extensive-Stage Small Cell Lung Cancer — An Interview with Prof Martin Reck · 41 min · Season 24 Episode 41Featuring an interview with Prof Martin Reck, including the following topics: • Case: A woman in her mid 70s with extensive-stage small cell lung cancer (ES-SCLC) experiences a…
- Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances · 59 min · Season 24 Episode 40Dr Christine L Hann from the Johns Hopkins University School of Medicine in Baltimore, Maryland, and Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts…
- EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances · 57 min · Season 24 Episode 39Dr Suresh S Ramalingam and Dr Helena Yu discuss the selection and sequencing of therapy for patients with EGFR mutation-positive non-small cell lung cancer and summarize major…
- Lung Cancer — 5-Minute Journal Club with Dr Natalie Vokes: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays · 27 min · Season 24 Episode 38Dr Natalie Vokes from The University of Texas MD Anderson Cancer Center in Houston discusses recent developments with circulating tumor DNA assays in the management of lung…
- Extensive-Stage Small Cell Lung Cancer — Current Patterns of Care with First-Line and Maintenance Therapy · 60 min · Season 24 Episode 37Dr Hossein Borghaei from Fox Chase Cancer Center in Philadelphia, Pennsylvania, and Dr Anne Chiang from Yale Cancer Center in New Haven, Connecticut, discuss key clinical trial…








